Lilly names new head of cancer drug business

Back to TopCommentsE-mailPrintBookmark and Share

Eli Lilly and Co. on Friday named company insider Sue Mahony as president of its cancer drug business.

Mahony is replacing John Johnson, who resigned Jan. 28 to become CEO of East Brunswick, N.J.-based biotechnology company Savient Pharmaceuticals Inc. Johnson is the former CEO of ImClone Systems, which Lilly acquired in 2008.

The change is effective immediately. Mahony has worked at Eli Lilly for about 10 years, the company said. Before her promotion she was in charge of human resources and diversity.

The company said her earlier positions included general manager of its Canadian business. She worked for other drugmakers, including Amgen Inc., Bristol-Myers Squibb Co., and Schering-Plough Corp. for about 10 years before joining Eli Lilly.

Mahony was featured as a "Woman of Influence" by IBJ in 2010.

The company said Steve Fry will assume Mahony's previous human resources and diversity position. Fry was in charge of human resources for Lilly's bio-medicines and emerging markets units.


Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ